1 Min Read
* Teva announces exclusive launch of generic Axiron® in the United States
* Teva Pharmaceutical industries ltd says launch of generic Axiron topical solution CIII, 30 mg/1.5 ml, in U.S. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.